Cannabinoids Compliance Concentrates DEA 
Canna Law Blog
OCTOBER 17, 2020
The Canna Law Blog has been writing about the Drug Enforcement Agency’s (DEA) interim final rule (IFR) on hemp since its August publication in the Federal Register: Watch Out! The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. The DEA Does Not Want You To Worry About Its New Hemp Rule.
Canna Law Blog
MAY 16, 2022
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. As many of our readers will know, the 2018 Farm Bill defines hemp as cannabis with a THC concentration of not more than 0.3 Challenging the DEA hemp rule.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Law Blog
MAY 16, 2022
The Drug Enforcement Administration (DEA) issued an interim final rule on hemp (“DEA hemp rule” or “rule”) on August 20, 2020. As many of our readers will know, the 2018 Farm Bill defines hemp as cannabis with a THC concentration of not more than 0.3 Challenging the DEA hemp rule.
Canna Law Blog
SEPTEMBER 28, 2020
On August 21, the Drug Enforcement Agency (the “DEA”) released an Interim Final Rule (the “ Rule ”), which, in part, suggests that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 percent on a dry weight basis. Emphasis added).
SpeedWeed
MARCH 11, 2021
As anticipated, Delta-8 tetrahydrocannabinol (“Delta-8 THC”) has become the hottest, most flourishing cannabinoid currently found on the U.S. To our knowledge, Delta-8 THC, unlike CBD, has not been approved or investigated by the FDA as a new drug ingredient, which means the Drug Exclusion Rule should not apply to this cannabinoid.
SpeedWeed
APRIL 27, 2021
Delta-8 THC, aka delta-8, the intoxicating cannabinoid synthesized from hemp, is making waves across the United States, and especially in states where marijuana remains illegal. Many states are now scrambling to close legal loopholes in their drug laws to bring delta-8 into regulatory compliance. delta-9 THC. Look for test cases soon.
Cannabis Law Report
SEPTEMBER 23, 2019
Marijuana and Cannabinoids: Health, Research and Regulatory Considerations (Position Paper). 1 Simultaneously, the AAFP acknowledges preliminary evidence indicates marijuana and cannabinoids may have potential therapeutic benefits, while also recognizing subsequent negative public health and health outcomes associated with cannabis use.
Expert insights. Personalized for you.
94 
Let's personalize your content